Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06859827

Role of CMR-FT in Assessment of HCM and Athlete's Heart.

Using cardiac MRI feature tracking to asses myocardial motion differences in athlete's heart and discovered hypertrophic cardiomyopathy patients to increase diagnostic accuracy of hypertrophic cardiomyopathy.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Conditions

Hypertrophic Cardiomyopathies Aortic Stenosis, Subvalvular Aortic Valve Disease Aortic Valve Stenosis Athlete Heart Cardiomyopathies Cardiomyopathy, Hypertrophic Cardiovascular Diseases Heart Diseases Heart Valve Diseases

Age range

20 year–50 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Sohag University hospital

Sohag, Sohag Governorate, 82511, Egypt

About this study

Cardiac MRI is the gold standard for assessing cardiac function without significant limitations of anatomical restrictions. CMR-FT helps in assessment of myocardial deformation on routinely obtained by steady state free precision (SSFP) cine images. CMR-FT is used in cardiac research and became common in clinical practice. It has been used in assessment of wide spectrum of cardiac diseases and provides for comprehensive and reliable assessments of heart function.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients suspected to be hypertrophic cardiomyopathy by echocardiography..
  • Athletes and heavy workers,, healthy volunteers also included.

Exclusion criteria

  • Patients with absolute or relative contraindications to magnetic resonance imaging (e.g intra-ocular metallic foreign body, claustrophobia, etc) or contra-indication to MRI contrast medium.
  • Clinical morbidities with absolute contraindication to anesthesia during the examination in un-cooperative patients where sedation is required.

Treatment and study plan

Primary outcomes

  1. Use of cardiac MRI feature tracking in detection of myocardial deformation abnormalities and diagnostic confirmation and detection of hypertrophic cardiomyopathy.

    Time frame: 6months to 12 months

    The main goal of the study is evaluating the role of Cardiac magnetic resonance feature tracking analysis in detection of myocardial deformation abnormalities in cases of hypertrophic cardio myopathy and compare it with physiological hypertrophy in athletes.

    Identification of strain patterns in hypertrophic cardiomyopathy.

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Official study title

The Role of Cardiac MRI Feature Tracking in Assessment of Hypertrophic Cardiomyopathy and Athlete's Heart.

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Mar 5, 2025
Registry last updated
Mar 5, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.